Articles published in Journal of Pharmacogenomics & Pharmacoproteomics have been cited by esteemed scholars and scientists all around the world. Journal of Pharmacogenomics & Pharmacoproteomics has got h-index 12, which means every article in Journal of Pharmacogenomics & Pharmacoproteomics has got 12 average citations.

Following are the list of articles that have cited the articles published in Journal of Pharmacogenomics & Pharmacoproteomics.

  2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010

Total published articles

30 56 30 30 13 4 7 15 13 20 25 12 35 13 2

Research, Review articles and Editorials

0 6 2 4 1 1 6 14 12 17 25 12 34 7 2

Research communications, Review communications, Editorial communications, Case reports and Commentary

30 50 28 8 2 0 1 1 1 2 0 0 0 0 0

Conference proceedings

0 0 0 0 0 0 35 102 83 47 82 0 0 0 0

Citations received as per Google Scholar, other indexing platforms and portals

35 55 58 71 61 49 63 48 72 63 23 8 6 0 0
Journal total citations count 613
Journal impact factor 2.31
Journal 5 years impact factor 3.74
Journal cite score 4.86
Journal h-index 12
Important citations

Pharmacogenetic considerations in the treatment of Alzheimer's disease

CYP2D6 ir CYP2C19 gen? polimorfizm? ?taka klinikiniam antidepresant? efektyvumui gydant vidutinio sunkumo ir sunki? depresij?

Onkolojik ilaç geli?tirilmesinde yeni nesil dizileme teknolojisine dayal? farmasötik uygulamalar

Conjugar a farmacogenética ea monitorização terapêutica de fármacos: uma estratégia na otimização e individualização da farmacoterapia

Pharmacogenetics Informed Decision Making in Adolescent Psychiatric Treatment: A Clinical

ESTABLISHING THE ROADMAP FOR THE IMPLEMENTATION OF GENOMIC MEDICINE AND PHARMACOGENOMICS IN THE UNITED ARAB EMIRATES

Pharmaceutical applications based on next generation sequencing technology in oncologic drug development

Diabetes Mellitus: Classification, Symptoms and Management: A Review

Pharmacogenomics and Phytochemicals

Pharmacogenomics and Personalized Medicine in Type 2 Diabetes

Pharmacogenomic Advancements For The Management Of Diabetes Mellitus

Personalized medicine: A step forward in dental treatment

Farmakogenetinio tyrimo vertinimas psichiatrijoje: retrospektyvi klinikini? atvej? analiz?

Knowledge, Attitudes, and Perceived Barriers toward Genetic Testing and Pharmacogenomics among Healthcare Workers in the United Arab Emirates: A Cross-Sectional Study

The Pharmaceutical Applications of Next Generation Sequencing in Oncology Drug Designing and Development

Pharmacogenetics informed decision making in adolescent psychiatric treatment: a clinical case report

Association between Paraoxonase-1 p. Q192R Polymorphism and Coronary Artery Disease susceptibility in the Colombian Population

Clinical relevant polymorphisms affecting clopidogrel pharmacokinetics and pharmacodynamics: Insights from the Puerto Rico Newborn Screening Program

CYP2D6 ir CYP2C19 gen? polimorfizm? ?taka klinikiniam antidepresant? efektyvumui gydant vidutinio sunkumo ir sunki? depresij?

Onkolojik ilaç geli?tirilmesinde yeni nesil dizileme teknolojisine dayal? farmasötik uygulamalar